These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29414245)

  • 1. Bifunctional fusion proteins containing the sequence of the bradykinin homologue maximakinin: activities at the rat bradykinin B
    Charest-Morin X; Lodge R; Marceau F
    Can J Physiol Pharmacol; 2018 May; 96(5):459-470. PubMed ID: 29414245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B
    Charest-Morin X; Bachelard H; Jean M; Marceau F
    PeerJ; 2017; 5():e2911. PubMed ID: 28133580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifunctional ligands of the bradykinin B
    Marceau F; Bawolak MT; Fortin JP; Morissette G; Roy C; Bachelard H; Gera L; Charest-Morin X
    Peptides; 2018 Jul; 105():37-50. PubMed ID: 29802875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged signalling and trafficking of the bradykinin B2 receptor stimulated with the amphibian peptide maximakinin: insight into the endosomal inactivation of kinins.
    Bawolak MT; Roy C; Gera L; Marceau F
    Pharmacol Res; 2012 Feb; 65(2):247-53. PubMed ID: 22108573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green fluorescent protein fused to peptide agonists of two dissimilar G protein-coupled receptors: novel ligands of the bradykinin B2 (rhodopsin family) receptor and parathyroid hormone PTH1 (secretin family) receptor.
    Charest-Morin X; Fortin JP; Bawolak MT; Lodge R; Marceau F
    Pharmacol Res Perspect; 2013 Oct; 1(1):e00004. PubMed ID: 25505558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates.
    Bachvarov DR; Houle S; Bachvarova M; Bouthillier J; Adam A; Marceau F
    J Pharmacol Exp Ther; 2001 Apr; 297(1):19-26. PubMed ID: 11259523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation.
    Savard M; Barbaz D; Bélanger S; Müller-Esterl W; Bkaily G; D'orléans-Juste P; Coté J; Bovenzi V; Gobeil F
    J Cell Physiol; 2008 Jul; 216(1):234-44. PubMed ID: 18264983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heteromerization Between the Bradykinin B2 Receptor and the Angiotensin-(1-7) Mas Receptor: Functional Consequences.
    Cerrato BD; Carretero OA; Janic B; Grecco HE; Gironacci MM
    Hypertension; 2016 Oct; 68(4):1039-48. PubMed ID: 27550920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two novel non-peptide antagonists at the rabbit bradykinin B2 receptor.
    Marceau F; Houle S; Bouthillier J; Said NB; Garratt PJ; Dziadulewicz EK
    Peptides; 2001 Sep; 22(9):1397-402. PubMed ID: 11514020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopeptidase-activated latent ligands of the histamine receptor-1.
    Gera L; Roy C; Charest-Morin X; Marceau F
    Int Immunopharmacol; 2013 Nov; 17(3):677-83. PubMed ID: 24016859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Close association of B2 bradykinin receptors with P2Y2 ATP receptors.
    Yashima S; Shimazaki A; Mitoma J; Nakagawa T; Abe M; Yamada H; Higashi H
    J Biochem; 2015 Aug; 158(2):155-63. PubMed ID: 25713410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cleavable signal peptide enhances cell surface delivery and heterodimerization of Cerulean-tagged angiotensin II AT1 and bradykinin B2 receptor.
    Quitterer U; Pohl A; Langer A; Koller S; Abdalla S
    Biochem Biophys Res Commun; 2011 Jun; 409(3):544-9. PubMed ID: 21600887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal fusion of eGFP to the bradykinin B2 receptor strongly affects down-regulation but not receptor internalization or signaling.
    Kalatskaya I; Schüssler S; Seidl C; Jochum M; Faussner A
    Biol Chem; 2006 May; 387(5):603-10. PubMed ID: 16740132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ßarrestins in bradykinin B2 receptor-mediated signalling.
    Zimmerman B; Simaan M; Akoume MY; Houri N; Chevallier S; Séguéla P; Laporte SA
    Cell Signal; 2011 Apr; 23(4):648-59. PubMed ID: 21145390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological effects of recombinant human tissue kallikrein on bradykinin B2 receptors.
    Charest-Morin X; Raghavan A; Charles ML; Kolodka T; Bouthillier J; Jean M; Robbins MS; Marceau F
    Pharmacol Res Perspect; 2015 Mar; 3(2):e00119. PubMed ID: 26038695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue kallikrein actions at the rabbit natural or recombinant kinin B2 receptors.
    Houle S; Molinaro G; Adam A; Marceau F
    Hypertension; 2003 Mar; 41(3):611-7. PubMed ID: 12623967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of B2 receptor signaling by AltB2R, a newly identified alternative protein encoded in the human bradykinin B2 receptor gene.
    Gagnon M; Savard M; Jacques JF; Bkaily G; Geha S; Roucou X; Gobeil F
    J Biol Chem; 2021; 296():100329. PubMed ID: 33497625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor.
    Blaes N; Pécher C; Mehrenberger M; Cellier E; Praddaude F; Chevalier J; Tack I; Couture R; Girolami JP
    Am J Physiol Renal Physiol; 2012 Jul; 303(2):F293-303. PubMed ID: 22573379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and pharmacological characterization of the human bradykinin subtype 2 receptor produced in mammalian cells using the Semliki Forest virus system.
    Shukla AK; Haase W; Reinhart C; Michel H
    Biol Chem; 2006 May; 387(5):569-76. PubMed ID: 16740128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor.
    Fathy DB; Kyle DJ; Leeb-Lundberg LM
    Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.